Industry and Consumer Advocates Square Off Regarding Social Media

Industry and Consumer Advocates Square Off Regarding Social Media

An Analysis of Who Submitted Comments to FDA

This article presents an overview of the types of organizations that submitted comments versus those that made presentations at the November 2009 public hearing. It also includes general comments from the pharma industry regarding the process by which the FDA should regulate the Internet and social media. Also presented in this article are the comments submitted by consumer advocates and individuals who generally supported more strict regulation across the board.

• Who Submitted Comments?
• Presenters Vs. Commentators
• Pfizer Asks for New FDA Regulations
• First Amendment Concerns
• AstraZeneca Proposes Social Media Principles
• Merck Encourages Ongoing Dialogue
• Most Consumer Advocates Are Anti-Pharma Marketing

Read this article now. It’s FREE…

Download PDF file

Also see:

• Overcoming Space Limitations in Social Media
• Accountability for Pharma Content on Social Media Sites
• Solving the Social Media Adverse Event Reporting Problem
• Special Report: FDA’s Regulation of Drug & Device Promotion via the Internet & Social Media

PMN93-01
Issue: Vol. 9, No. 3: March 2010
Word Count: 2804

Find other articles in related Topic Areas:

• Direct-to-Consumer (DTC) Advertising & Marketing
• eMarketing and ePromotion
• Regulatory Compliance